Eli Lilly & Co. (LLY) Tops Q3 EPS by 2c; Reviewing Strategic Alternatives for Elanco Animal Health

Go back to Eli Lilly & Co. (LLY) Tops Q3 EPS by 2c; Reviewing Strategic Alternatives for Elanco Animal Health

Lilly Reports Third-Quarter Results, Announces Strategic Review of Elanco Animal Health

October 24, 2017 6:25 AM EDT

INDIANAPOLIS, Oct. 24, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced financial results for the third quarter of 2017.

$ in millions, except

per share data

Third Quarter

... More